Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Seth A Climans"'
Autor:
Craig Erker, Magimairajan Issai Vanan, Valérie Larouche, Liana Nobre, Chantel Cacciotti, Stéphanie Vairy, Shayna Zelcer, Adam Fleming, Eric Bouffet, Nada Jabado, Geneviève Legault, Samuele Renzi, Tara McKeown, Bruce Crooks, Nirav Thacker, Vijay Ramaswamy, Hallie Coltin, Lucie Lafay-Cousin, Sylvia Cheng, Juliette Hukin, Seth Andrew Climans, Mary Jane Lim-Fat, Sarah McKillop, Sarah Lapointe, Mélanie Alves, Julie Bennett, Uri Tabori, Sébastien Perreault
Publikováno v:
Current Oncology, Vol 31, Iss 7, Pp 4022-4029 (2024)
Background: The treatment of BRAF V600E gliomas with BRAF inhibitors (BRAFis) and MEK inhibitors (MEKis) has been increasingly integrated into clinical practice for pediatric low-grade gliomas (PLGGs) and pediatric high-grade gliomas (HGGs). However,
Externí odkaz:
https://doaj.org/article/18a6d0e5930647838048e65c909b0585
Publikováno v:
Canadian Journal of Infectious Diseases and Medical Microbiology, Vol 25, Iss 3, Pp 133-134 (2014)
Externí odkaz:
https://doaj.org/article/034679e8b18648c78e9085d86746084b
Autor:
Michelle Paff, Nardin Samuel, Noor Alsafwani, Darcia Paul, Phedias Diamandis, Seth A. Climans, Walter Kucharczyk, Mandy Yi Rong Ding, Andrew F. Gao, Andres M. Lozano
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-6 (2022)
Abstract Background Leukoencephalopathy with brain calcifications and cysts (LCC; also known as Labrune syndrome) is a rare genetic microangiopathy caused by biallelic mutations in SNORD118. The mechanisms by which loss-of-function mutations in SNORD
Externí odkaz:
https://doaj.org/article/5ca03fa18bd84c048808dd4b3d6b62b0
Publikováno v:
Current Oncology; Volume 30; Issue 4; Pages: 4311-4328
Primary central nervous system (CNS) tumours are heterogeneous, with different treatment pathways and prognoses depending on their histological and molecular classification. Due to their anatomical location, all CNS tumours, regardless of malignancy,
Autor:
Angela Sekely, Lori J Bernstein, Kristin L Campbell, Warren P Mason, Normand Laperriere, Navya Kalidindi, Rosemarylin Or, Ronald Ramos, Seth A Climans, Gregory R Pond, Barbara Ann Millar, David Shultz, Derek S Tsang, Gelareh Zadeh, Kim Edelstein
Publikováno v:
Neuro-Oncology Practice. 10:89-96
Background In addition to poor survival rates, individuals with glioblastoma (GBM) are at risk of neurocognitive impairment due to multiple factors. This study aimed to characterize neurocognitive impairment, neurobehavioral symptoms, fatigue, sleep
Publikováno v:
Journal of Neuro-Oncology. 159:665-674
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. :1-6
Background: Cerebral radionecrosis, a subacute or late effect of radiotherapy, can be debilitating and difficult to treat. Steroids can reduce symptoms, but have significant long-term side effects. Bevacizumab has been shown to reduce edema and other
Publikováno v:
Neuro Oncol
Background Malignant gliomas are treated with temozolomide chemoradiotherapy. Because pneumocystis pneumonia (PCP) can occur in patients receiving temozolomide, the product monograph recommends PCP prophylaxis during temozolomide chemoradiotherapy. N
Autor:
Yajur, Iyengar, Julien, Hébert, Seth A, Climans, Alexandra, Muccilli, Sydney, Lee, Abhilasha P, Boruah, Kiran T, Thakur, Jonathon, Solnik, Richard A, Wennberg, Gregory S, Day, David F, Tang-Wai
Publikováno v:
Frontiers in Neurology. 13
BackgroundFor patients with anti-N-methyl-D-aspartate receptor encephalitis (NMDARE) and ovarian teratoma, “conservative” surgical approaches (complete or partial unilateral oophorectomy or bilateral partial oophorectomies) are associated with cl
Publikováno v:
Epilepsy and Behavior Case Reports, Vol 7, Iss C, Pp 58-60 (2017)
Externí odkaz:
https://doaj.org/article/187c08432b914aaab3f41ac7b54e04de